• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茯苓酸调节沉默信息调节因子6的活性以减轻脂质代谢紊乱。

Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders.

作者信息

Pan Zhi-Sen, Chen Yan-Ling, Tang Kai-Jia, Liu Zhang-Zhou, Liang Jia-Li, Guan Yan-Hao, Xin Xiao-Yi, Liu Chang-Hui, Shen Chuang-Peng

机构信息

Department of Traditional Chinese Medicine, The First People's Hospital of Kashgar Prefecture, Kashgar, Xinjiang Uyghur Autonomous Region 844000, P.R. China.

Department of Endocrinology, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China.

出版信息

Exp Ther Med. 2023 May 15;26(1):320. doi: 10.3892/etm.2023.12019. eCollection 2023 Jul.

DOI:10.3892/etm.2023.12019
PMID:37273757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236048/
Abstract

Pachymic acid (Pac), a major bioactive constituent of , is an antioxidant that inhibits triglyceride (TG) accumulation. To the best of our knowledge, the present study investigated for the first time whether Pac activated sirtuin 6 (SIRT6) signaling to alleviate oleic acid (OA)-palmitic acid (PA)-induced lipid metabolism disorders in mouse primary hepatocytes (MPHs). In the present study, MPHs challenged with Pac were used to test the effects of Pac on intracellular lipid metabolism. Molecular docking studies were performed to explore the potential targets of Pac in defending against lipid deposition. MPHs isolated from liver-specific SIRT6-deficient mice were subjected to OA + PA incubation and treated with Pac to determine the function and detailed mechanism. It was revealed that Pac activated SIRT6 by increasing its expression and deacetylase activity. Pa prevented OA + PA-induced lipid deposition in MPHs in a dose-dependent manner. Pac (50 µM) administration significantly reduced TG accumulation and increased fatty acid oxidation rate in OA + PA-incubated MPHs. Meanwhile, as per the results of molecular docking and relative mRNA levels, Pac activated SIRT6 and increased SIRT6 deacetylation levels. Furthermore, SIRT6 deletions in MPHs abolished the protective effects of Pac against OA + PA-induced hepatocyte lipid metabolism disorders. The present study demonstrated that Pac alleviates OA + PA-induced hepatocyte lipid metabolism disorders by activating SIRT6 signaling. Overall, SIRT6 signaling increases oxidative stress burden and promotes hepatocyte lipolysis.

摘要

茯苓酸(Pac)是茯苓的主要生物活性成分,是一种抑制甘油三酯(TG)积累的抗氧化剂。据我们所知,本研究首次探讨了Pac是否通过激活沉默调节蛋白6(SIRT6)信号通路来减轻油酸(OA)-棕榈酸(PA)诱导的小鼠原代肝细胞(MPH)脂质代谢紊乱。在本研究中,用Pac处理的MPH来测试Pac对细胞内脂质代谢的影响。进行分子对接研究以探索Pac在抵御脂质沉积中的潜在靶点。对从肝脏特异性SIRT6缺陷小鼠分离的MPH进行OA + PA孵育并用Pac处理,以确定其功能和详细机制。结果表明,Pac通过增加SIRT6的表达和脱乙酰酶活性来激活SIRT6。Pac以剂量依赖性方式预防OA + PA诱导的MPH脂质沉积。给予Pac(50µM)可显著降低OA + PA孵育的MPH中的TG积累并提高脂肪酸氧化率。同时,根据分子对接和相对mRNA水平的结果,Pac激活SIRT6并提高SIRT6的去乙酰化水平。此外,MPH中SIRT6的缺失消除了Pac对OA + PA诱导的肝细胞脂质代谢紊乱的保护作用。本研究表明,Pac通过激活SIRT6信号通路减轻OA + PA诱导的肝细胞脂质代谢紊乱。总体而言,SIRT6信号通路增加氧化应激负担并促进肝细胞脂解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/29d3d2a44bd3/etm-26-01-12019-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/462aa267d0ae/etm-26-01-12019-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/f54d40487055/etm-26-01-12019-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/4c5f8a786220/etm-26-01-12019-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/a660c109c8ef/etm-26-01-12019-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/9890a1175d8f/etm-26-01-12019-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/15a800cb19f9/etm-26-01-12019-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/29d3d2a44bd3/etm-26-01-12019-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/462aa267d0ae/etm-26-01-12019-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/f54d40487055/etm-26-01-12019-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/4c5f8a786220/etm-26-01-12019-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/a660c109c8ef/etm-26-01-12019-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/9890a1175d8f/etm-26-01-12019-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/15a800cb19f9/etm-26-01-12019-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/10236048/29d3d2a44bd3/etm-26-01-12019-g06.jpg

相似文献

1
Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders.茯苓酸调节沉默信息调节因子6的活性以减轻脂质代谢紊乱。
Exp Ther Med. 2023 May 15;26(1):320. doi: 10.3892/etm.2023.12019. eCollection 2023 Jul.
2
Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD.人参皂苷Rc作为一种新型的SIRT6激活剂,可保护小鼠免受高脂饮食诱导的非酒精性脂肪性肝病的影响。
J Ginseng Res. 2023 May;47(3):376-384. doi: 10.1016/j.jgr.2020.07.005. Epub 2020 Aug 4.
3
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.大黄素通过激活法尼醇 X 受体通路缓解高脂饮食诱导的小鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2021 Oct 28;279:114340. doi: 10.1016/j.jep.2021.114340. Epub 2021 Jun 22.
4
Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake.薯蓣皂苷元通过调节 SIRT6 相关的脂肪酸摄取来减轻 2 型糖尿病非酒精性脂肪肝疾病。
Phytomedicine. 2023 Mar;111:154661. doi: 10.1016/j.phymed.2023.154661. Epub 2023 Jan 10.
5
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.肝源性 Krüppel 样因子 16(KLF16)靶向 PPARα 以改善脂肪性肝炎和胰岛素抵抗。
Gut. 2021 Nov;70(11):2183-2195. doi: 10.1136/gutjnl-2020-321774. Epub 2020 Nov 30.
6
Sirtuin 1 is involved in oleic acid-induced calf hepatocyte steatosis via alterations in lipid metabolism-related proteins.Sirtuin 1 通过改变与脂质代谢相关的蛋白参与油酸诱导的小牛肝细胞脂肪变性。
J Anim Sci. 2021 Oct 1;99(10). doi: 10.1093/jas/skab250.
7
Wolf Extract Ameliorates Hepatic Steatosis through Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation of Autophagy via AMPK Activation.狼提取物通过激活 AMPK 来调节脂质代谢、抑制内质网应激和激活自噬,从而改善肝脂肪变性。
Int J Mol Sci. 2019 Sep 27;20(19):4801. doi: 10.3390/ijms20194801.
8
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.芝麻素通过上调法尼醇 X 受体缓解 HFD 诱导的小鼠肝脂质积累。
J Ethnopharmacol. 2020 Jun 12;255:112776. doi: 10.1016/j.jep.2020.112776. Epub 2020 Mar 20.
9
Palmitic acid follows a different metabolic pathway than oleic acid in human skeletal muscle cells; lower lipolysis rate despite an increased level of adipose triglyceride lipase.在人类骨骼肌细胞中,棕榈酸与油酸遵循不同的代谢途径;尽管脂肪甘油三酯脂肪酶水平升高,但脂肪分解率较低。
Biochim Biophys Acta. 2012 Oct;1821(10):1323-33. doi: 10.1016/j.bbalip.2012.07.001. Epub 2012 Jul 13.
10
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.樟芝及其复合成分去氢表雄酮酸通过上调 ALDH2 活性来减轻非酒精性脂肪肝疾病。
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.

引用本文的文献

1
Progress in the study of bioactivity, chemical composition and pharmacological mechanism of action in (F.A. Wolf) Ryvarden & Gilb.(F.A. 沃尔夫)里瓦尔登和吉尔伯的生物活性、化学成分及药理作用机制研究进展
Front Pharmacol. 2025 Mar 3;16:1521235. doi: 10.3389/fphar.2025.1521235. eCollection 2025.

本文引用的文献

1
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.非酒精性脂肪性肝病:代谢、遗传、表观遗传和环境危险因素。
Int J Environ Res Public Health. 2021 May 14;18(10):5227. doi: 10.3390/ijerph18105227.
2
Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease.游离脂肪酸受体作为肝脏疾病的介质和治疗靶点
Front Physiol. 2021 Apr 7;12:656441. doi: 10.3389/fphys.2021.656441. eCollection 2021.
3
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation.
SIRT6作为连接P53和NRF2的关键事件,通过抑制氧化应激和促进肝细胞增殖来对抗对乙酰氨基酚诱导的肝毒性。
Acta Pharm Sin B. 2021 Jan;11(1):89-99. doi: 10.1016/j.apsb.2020.06.016. Epub 2020 Jul 4.
4
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants.非酒精性脂肪性肝病中的氧化应激:营养素和食物污染物的作用。
Biomolecules. 2020 Dec 21;10(12):1702. doi: 10.3390/biom10121702.
5
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.肝源性 Krüppel 样因子 16(KLF16)靶向 PPARα 以改善脂肪性肝炎和胰岛素抵抗。
Gut. 2021 Nov;70(11):2183-2195. doi: 10.1136/gutjnl-2020-321774. Epub 2020 Nov 30.
6
Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.汉黄芩苷对非酒精性脂肪性肝病小鼠炎症反应及氧化应激的影响。
Pharm Biol. 2020 Dec;58(1):1177-1183. doi: 10.1080/13880209.2020.1845747.
7
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
8
Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase.禁食诱导的 FGF21 信号通过 JMJD3 组蛋白去甲基酶激活肝自噬和脂质降解。
Nat Commun. 2020 Feb 10;11(1):807. doi: 10.1038/s41467-020-14384-z.
9
effect of pachymic acid on the activity of Cytochrome P450 enzymes.茯苓酸对细胞色素P450酶活性的影响。
Xenobiotica. 2020 Aug;50(8):913-918. doi: 10.1080/00498254.2020.1727062. Epub 2020 Feb 12.
10
A high-fat diet reverses metabolic disorders and premature aging by modulating insulin and IGF1 signaling in SIRT6 knockout mice.高脂肪饮食通过调节 SIRT6 敲除小鼠的胰岛素和 IGF1 信号转导逆转代谢紊乱和早衰。
Aging Cell. 2020 Mar;19(3):e13104. doi: 10.1111/acel.13104. Epub 2020 Jan 22.